Progression of Retinal Pigment Epithelium Atrophy in Patients with Long-Term Anti-Vegf Treatment for Exudative Age-Related Macular Degeneration
References
- 1. Ambati J, Fowler BJ. Mechanisms of age-related macular degeneration // Neuron. 2012;75(1):26-39
- 2. Ba J, Peng R-S, Xu D, et al. Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and metaanalysis // Drug Design, Development and Therapy. 2015;9:5397-5405
- 3. Broadhead G.K, Hong T, Chang A. Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration // Acta Ophthalmologica, 2014; 92:8 713-723<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1111/aos.12463" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/aos.12463</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">24925048</dgpm:pub-id>
- 4. Enslow R, Bhuvanagiri S, Vegunta S, Cutler B, Neff M, Stagg B. Association of Anti-VEGF Injections with Progression of Geographic Atrophy // Ophthalmology and Eye Diseases. 2016;8:31-32
- 5. Ferris FL. Senile macular degeneration: review of epidemiologic features // Am J Epidemiol, 1983; 118:132-151
- 6. Gemenetzi M, Lotery AJ, Patel PJ. Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents. Eye. 2017;31(1):1-9.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1038/eye.2016.208" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/eye.2016.208</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmcid">5233933</dgpm:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">27716750</dgpm:pub-id>
- 7. Ramenaden E, Rosenfeld P. Can Anti-VEGF Cause GA in Wet AMD? // Available: http://www.retinaspecialist.com/article/can-antivegf-cause-ga-inwet-amd
- 8. Renu Jogi. Basic Ophthalmology, 4th Edition. New Delhi: Jaypee Brothers Medical Publishers (P); 2009; 1-9
- 9. Resident population by major age group at the beginning of the year. Available: http://data.csb.gov.lv/pxweb/en/Sociala/Sociala__ikgad__iedz__iedzskaits/IS0022.px/?rxid=cd
- 10. Sparrrow JR, Hicks D, Hamel CP. The Retinal Pigment Epithelium in Health and Disease // Current molecular medicine. 2010;10(9):802-823
- 11. Veritti D, Sarao V, Lanzetta P. Neovascular agerelated macular degeneration // Ophthalmologica, 2012; 1:11-20
- 12. Xu Y, Tan CS. Safety and complications of intravitreal injections performed in an Asian population Singapore // Int Ophthalmol, 2017; 37(2):325-332
- 13. Yorston D. Anti-VEGF drugs in the prevention of blindness // Community Eye Health. 2014;27(87):44-46.
Language: English
Page range: 9 - 13
Published on: Sep 25, 2018
Published by: Riga Stradins University
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Keywords:
Related subjects:
© 2018 Lita Jekabsone, Anete Kursite, Oskars Gertners, Guna Laganovska, published by Riga Stradins University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.